novel coronavirus pneumonia (COVID-19)
Conditions
Sponsors
China Academy of Chinese Medical Sciences; Zhongnan Hospital of Wuhan University
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: (1) Comply with the diagnostic criteria for general type COVID-19 in the "Diagnosis and Treatment Program for COVID-19"(trial version 5th). (2) Agree to participate in the study and the patient or legal guardian signs the informed consent form.
Exclusion criteria
Exclusion criteria: (1) Patients who can not guarantee compliance of using TCM during the treatment period, or patients who are difficult to take medicine by oral or nasal route. (2) Patients who have been more than 7 days since definite diagnosis. (3) Patients with severe primary respiratory disease or other pathogenic microbial pneumonia that needs to be identified with COVID-19. (4) Maternal, or patients with a positive urine pregnancy test. (5) Patients with other systemic malignant diseases such as malignant tumors, mental illnesses, etc., which the researchers consider unsuitable for participation in the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Rate of conversion to severe or critical illness; | — |
Secondary
| Measure | Time frame |
|---|---|
| Blood routine test;Psychological outcomes;Chest imaging;Blood biochemical test;Rate of disisolation;TCM symptom;Body temperature; | — |
Countries
China
Contacts
Public ContactHuang Luqi; Li Zhiqiang
China Academy of Chinese Medical Sciences
Outcome results
None listed